Ibis Inc.
Ibis Inc. Fundamental Analysis
Ibis Inc. (9343.T) shows strong financial fundamentals with a PE ratio of 14.24, profit margin of 16.96%, and ROE of 33.77%. The company generates $5.0B in annual revenue with strong year-over-year growth of 13.18%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 75.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 9343.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent9343.T demonstrates superior asset utilization.
Valuation Score
Moderate9343.T shows balanced valuation metrics.
Growth Score
Moderate9343.T shows steady but slowing expansion.
Financial Health Score
Excellent9343.T maintains a strong and stable balance sheet.
Profitability Score
Moderate9343.T maintains healthy but balanced margins.
Key Financial Metrics
Is 9343.T Expensive or Cheap?
P/E Ratio
9343.T trades at 14.24 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 9343.T's PEG of 3.96 indicates potential overvaluation.
Price to Book
The market values Ibis Inc. at 4.17 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 10.34 times EBITDA. This signals the market has high growth expectations.
How Well Does 9343.T Make Money?
Net Profit Margin
For every $100 in sales, Ibis Inc. keeps $16.96 as profit after all expenses.
Operating Margin
Core operations generate 24.02 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $33.77 in profit for every $100 of shareholder equity.
ROA
Ibis Inc. generates $20.27 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ibis Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Ibis Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
9343.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
14.24
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.96
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.17
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.41
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.55
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.34
vs 25 benchmark
ROA
Return on assets percentage
0.20
vs 25 benchmark
ROCE
Return on capital employed
0.39
vs 25 benchmark
How 9343.T Stacks Against Its Sector Peers
| Metric | 9343.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 14.24 | 34.43 | Better (Cheaper) |
| ROE | 33.77% | 1135.00% | Weak |
| Net Margin | 16.96% | -134663.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 2.55 | 5.77 | Strong Liquidity |
| ROA | 20.27% | -310462.00% (disorted) | Strong |
9343.T outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ibis Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
173.31%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
2114.17%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
3300.79%
Industry Style: Growth, Innovation, High Beta
High Growth